Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Pfizer (NY: PFE)
40.34 USD  -0.17 (-0.42%)
Official Closing Price  /  Updated: 7:59 PM EST, Jan 21, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 21,931,400
Open 40.38
Bid (Size) 40.21 (10)
Ask (Size) 40.59 (5)
Prev. Close 40.51
Today's Range 40.19 - 40.66
52wk Range 33.97 - 44.56
Shares Outstanding 5,849,571,048
Dividend Yield 3.37%
Performance
YTD
+3.07%
+3.07%
1 Month
+2.59%
+2.59%
3 Month
+10.73%
+10.73%
6 Month
-6.38%
-6.38%
1 Year
-4.57%
-4.57%
Top News
More News
Global Brain Tumor Drugs Market Expected To Exceed $3 Billion Through 2022
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets
Insilico Medicine is pleased to announce that it has entered into a research collaboration with Pfizer Inc. (NYSE: PFE) to utilize Insilico's machine learning technology and proprietary Pandomics... Read More
from PR Newswire
More News
Read More
September 18th Options Now Available For Pfizer (PFE)
category Stocks
from Market News Video
Global Brain Tumor Drugs Market Expected to Exceed $3 Billion Through 2022
from PR Newswire
VYM, PG, WFC, PFE: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Pharma firms not making enough progress against superbugs - report
category companyNews
from Reuters: Company News
Barron's Picks And Pans: Apple, Boeing, Disney, Tesla And More
category TSLA , Market News , GS , and 11 more.
from Benzinga
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer
category Market News , JNJ , MRK , and 2 more.
from Motley Fool
Cannabis Media Company The Fresh Toast Expands Again, Says It's Cash Positive
category PFE , News , Cannabis , and 6 more.
from Benzinga
2 Biotechs Battling Immune Diseases
category ABBV , AZN , RIGL , and 10 more.
from Motley Fool
Thinking about buying stock in Advanced Micro Devices, Canopy Growth Corp, Fitbit, Pfizer, or Snap?
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.